Medical device company DexCom (NASDAQ:DXCM) in Q1 CY2025, with sales up 12.5% year on year to $1.04 billion. The company ...

After this recent quarterly performance and the resultant increase in stock price, an important question arises: is DXCM ...

DexCom, Inc. (DXCM), with a market cap of $33.9 billion, is a leading medical device company specializing in continuous ...

DexCom Inc. closed 34.58% short of its 52-week high of $132.26, which the company reached on May 17th.

The medical instruments industry is currently undergoing a transformative phase, thanks to the rapid adoption of generative ...

Shares of DexCom Inc. DXCM shed 1.11% to $84.11 Tuesday, on what proved to be an all-around mixed trading session for the ...

DexCom's growth trend improved in 1Q25, but competition and shrinking market potential keep upside limited. Find out why DXCM ...

Dexcom (Nadsaq:DXCM) shares rose after hours today on first-quarter results that came in mixed compared to the consensus forecast.

DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Five Health and Fitness stocks to buy now are ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of ...

Shares of DexCom jumped over 15% to pace the S&P 500's advancers Friday, a day after the maker of glucose monitoring devices ...

In trading on Friday, shares of DexCom Inc (Symbol: DXCM) crossed above their 200 day moving average of $76.24, changing hands as high as $81.84 per share. DexCom Inc shares are currently trading ...